UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024043
Receipt number R000027688
Scientific Title Evaluation of morphology and function of meibomian glands in patients with benign prostatic hyperplasia
Date of disclosure of the study information 2016/09/13
Last modified on 2018/03/16 09:16:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of morphology and function of meibomian glands in patients with benign prostatic hyperplasia

Acronym

Evaluation of morphology and function of meibomian glands in patients with benign prostatic hyperplasia

Scientific Title

Evaluation of morphology and function of meibomian glands in patients with benign prostatic hyperplasia

Scientific Title:Acronym

Evaluation of morphology and function of meibomian glands in patients with benign prostatic hyperplasia

Region

Japan


Condition

Condition

patients with benign prostatic hyperplasia

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the relationship between morphology and function of meibomian glands, tear film related parameters and alopecia

Basic objectives2

Others

Basic objectives -Others

To investigate the relationship between morphology and function of meibomian glands, tear film related parameters and alopecia

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Ocular symptoms, Alopecia grading, tear film breakup time, lid margin abnormalities, ocular surface staining, meiboscore, meibum grading, Schirmer value, systemic disease, tear interferometry,

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Patients with benign prostatic hyperplasia diagnosed in internal medicine or urology

Key exclusion criteria

Subjects who have ocular diseases

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Reiko Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code


Address

626-11,Minaminakano, Minuma-Ku, Saitama City, Saitama, Japan

TEL

048-686-5588

Email

ritoh@za2.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Reiko Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code


Address

626-11, Minaminakano, Minuma-Ku, Saitama,

TEL

048-686-5588

Homepage URL


Email

ritoh@za2.so-net.ne.jp


Sponsor or person

Institute

Itoh Clinic
Ophthalmology

Institute

Department

Personal name



Funding Source

Organization

Itoh Clinic
Ophthalmology
Lid and meibomian gland working group

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

伊藤医院


Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 05 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 13 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Ocular symptoms, alopecia, lid margin abnormalities, ocular surface staining, tear film break up time, meiboscore, meibum grading, Schirmer value, tear interferometry, systematic disease


Management information

Registered date

2016 Year 09 Month 13 Day

Last modified on

2018 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027688


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name